Predictive Oncology completes $343.5 million PIPE financing to support ATH token treasury strategy
According to ChainCatcher, citing Globenewswire, Nasdaq-listed company Predictive Oncology has announced the completion of a $343.5 million PIPE financing. The company will use these funds to purchase ATH tokens on the open market to support its ATH token treasury strategy.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Summit (SMMT.US) surges after-hours following $2 billions investment from AstraZeneca (AZN.US) and joint drug development collaboration
Cancer drug developer Summit Therapeutics announced that AstraZeneca will make a strategic equity investment of $2 billion, and both parties will jointly develop drugs.
Crypto prices
More
